A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension
Clinical trial NCT06785454 · COMPLETED
Trial details
- NCT number
- NCT06785454
- Sponsor
- Mineralys Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2025-12-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.